Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bioventus Inc BVS

Healthcare Medical Instruments & Supplies
Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body’s natural healing process. Its portfolio of products is grouped into three areas. Its Pain Treatments include non-surgical pain injection therapies as well as peripheral nerve stimulation (PNS) products... see more

Recent & Breaking News (NDAQ:BVS)

Bioventus Appoints Mark Singleton as Chief Financial Officer

GlobeNewswire February 28, 2022

Bioventus to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 10, 2022

GlobeNewswire February 22, 2022

SWK Holdings Provides Portfolio Update Highlighting Recent Achievements

PR Newswire February 9, 2022

Bioventus Announces Preliminary Fourth Quarter and Full-Year 2021 Revenue

GlobeNewswire January 11, 2022

Bioventus to Present at the 40th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 28, 2021

Bioventus Appoints Michelle McMurry-Heath to Board of Directors

GlobeNewswire December 21, 2021

Bioventus Receives US FDA Clearance for BoneScalpel® Access(TM)

GlobeNewswire December 20, 2021

Bioventus to Expand Operations and Manufacturing in Memphis

GlobeNewswire November 18, 2021

Bioventus Announces Chief Financial Officer Transition Plan

GlobeNewswire November 15, 2021

Bioventus Reports Third Quarter Results; Updates Full-Year 2021 Financial Guidance

GlobeNewswire November 9, 2021

Sharon Klugewicz Joins Bioventus as Senior Vice President, Quality and Regulatory Affairs

GlobeNewswire November 1, 2021

Bioventus Completes the Acquisition of Misonix

GlobeNewswire October 29, 2021

Bioventus to Release Third Quarter of Fiscal Year 2021 Financial Results on November 9, 2021

GlobeNewswire October 27, 2021

Bioventus and Misonix Stockholders Approve the Acquisition of Misonix by Bioventus

GlobeNewswire October 26, 2021

BIOVENTUS INC. and MISONIX, INC. Announce Election Deadline of 5:00 p.m. New York City Time, on October 25, 2021 for Misonix Stockholders to Elect Form of Merger Consideration

GlobeNewswire October 18, 2021

DUROLANE® Among High-Molecular Weight Hyaluronic Acid Treatments Linked to Significant Improvements in Knee Osteoarthritis Pain by American Academy of Orthopaedic Surgeons

GlobeNewswire September 20, 2021

Misonix Reports Fourth Quarter and Fiscal Year 2021 Financial Results

GlobeNewswire September 2, 2021

Bioventus Proceeds with Option Structure Agreement with CartiHeal

GlobeNewswire August 30, 2021

Bioventus Invests in Trice Medical Minimally Invasive Technologies

GlobeNewswire August 25, 2021

Dave Crawford Joins Bioventus as Vice President, Investor Relations and Treasurer

GlobeNewswire August 23, 2021